Versant Venture Management, LLC 13F Holdings

CIK 0001560009

As of Sep 30, 2025, Versant Venture Management, LLC reported 9 positions worth $212.5M in its SEC Form 13F filing.

Top 9 holdings

SecurityTickerSectorSharesValue% of portfolio
LENZ THERAPEUTICS INCLENZHealthcare2,656,888 23.8M58.25%
MONTE ROSA THERAPEUTICS INCGLUEHealthcare5,652,922$41.9M19.72%
JADE BIOSCIENCES INCJBIO—1,525,820 3.2M6.20%
CRISPR THERAPEUTICS AGCRSPHealthcare148,831$9.6M4.54%
SKYE BIOSCIENCE INCSKYEHealthcare2,007,704$7.9M3.71%
CONTINEUM THERAPEUTICS INCCTNMHealthcare542,628$6.4M3.00%
REPARE THERAPEUTICS INCRPTXHealthcare2,646,657$4.7M2.19%
TEMPEST THERAPEUTICS INCTPSTHealthcare269,772$2.8M1.31%
ADVERUM BIOTECHNOLOGIES INCADVMHealthcare506,821$2.3M1.08%